CA1008770A - Therapeutic composition containing 1-(2-hydroxy-2-indanyl)-propylamine - Google Patents
Therapeutic composition containing 1-(2-hydroxy-2-indanyl)-propylamineInfo
- Publication number
- CA1008770A CA1008770A CA176,859A CA176859A CA1008770A CA 1008770 A CA1008770 A CA 1008770A CA 176859 A CA176859 A CA 176859A CA 1008770 A CA1008770 A CA 1008770A
- Authority
- CA
- Canada
- Prior art keywords
- indanyl
- propylamine
- hydroxy
- composition containing
- therapeutic composition
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired
Links
- QTZFSVVIXMRRLW-UHFFFAOYSA-N indanorex Chemical compound C1=CC=C2CC(C(N)CC)(O)CC2=C1 QTZFSVVIXMRRLW-UHFFFAOYSA-N 0.000 title 1
- 230000001225 therapeutic effect Effects 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
- A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
- A61K31/137—Arylalkylamines, e.g. amphetamine, epinephrine, salbutamol, ephedrine or methadone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C2601/00—Systems containing only non-condensed rings
- C07C2601/12—Systems containing only non-condensed rings with a six-membered ring
- C07C2601/14—The ring being saturated
Landscapes
- Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Epidemiology (AREA)
- Obesity (AREA)
- Child & Adolescent Psychology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Diabetes (AREA)
- Hematology (AREA)
- Emergency Medicine (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
FR7226162A FR2201882B1 (fr) | 1972-07-20 | 1972-07-20 |
Publications (1)
Publication Number | Publication Date |
---|---|
CA1008770A true CA1008770A (en) | 1977-04-19 |
Family
ID=9102129
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CA176,859A Expired CA1008770A (en) | 1972-07-20 | 1973-07-19 | Therapeutic composition containing 1-(2-hydroxy-2-indanyl)-propylamine |
Country Status (6)
Country | Link |
---|---|
US (1) | US3885045A (fr) |
BE (1) | BE801014A (fr) |
CA (1) | CA1008770A (fr) |
DE (1) | DE2336560C2 (fr) |
FR (1) | FR2201882B1 (fr) |
GB (1) | GB1375806A (fr) |
Families Citing this family (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE10142662B4 (de) * | 2001-08-31 | 2004-07-08 | Aventis Pharma Deutschland Gmbh | Derivate von C2-substituierten Indan-1-ol-Systemen und ihre Verwendung als Arzneimittel |
DE10142667B4 (de) * | 2001-08-31 | 2004-06-09 | Aventis Pharma Deutschland Gmbh | C2-substituierte Indan-1-ole und ihre Derivate und ihre Verwendung als Arzneimittel |
DE10142661B4 (de) * | 2001-08-31 | 2004-06-09 | Aventis Pharma Deutschland Gmbh | Mehrfach substituierte Indan-1-ol-Systeme und ihre Verwendung als Arzneimittel |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US2982783A (en) * | 1961-05-02 | Amevoevdanes | ||
US3072716A (en) * | 1959-03-18 | 1963-01-08 | Ciba Geigy Corp | Substituted indenes |
GB1139135A (en) * | 1965-10-01 | 1969-01-08 | Kefalas As | Aminoalkyl-substituted indanes and pharmaceutical compositions containing them |
US3657440A (en) * | 1968-04-23 | 1972-04-18 | Ciba Geigy Corp | Aminoalkyl-spirocycloalkanes as analgetic agents |
-
1972
- 1972-07-20 FR FR7226162A patent/FR2201882B1/fr not_active Expired
-
1973
- 1973-06-15 BE BE132357A patent/BE801014A/fr unknown
- 1973-06-29 GB GB3110773A patent/GB1375806A/en not_active Expired
- 1973-07-18 DE DE2336560A patent/DE2336560C2/de not_active Expired
- 1973-07-19 US US380542A patent/US3885045A/en not_active Expired - Lifetime
- 1973-07-19 CA CA176,859A patent/CA1008770A/en not_active Expired
Also Published As
Publication number | Publication date |
---|---|
US3885045A (en) | 1975-05-20 |
DE2336560B1 (de) | 1974-03-28 |
DE2336560A1 (de) | 1974-03-14 |
FR2201882A1 (fr) | 1974-05-03 |
DE2336560C2 (de) | 1974-10-31 |
BE801014A (fr) | 1973-10-01 |
FR2201882B1 (fr) | 1975-10-31 |
GB1375806A (fr) | 1974-11-27 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CA1010781A (en) | Insecticidal composition | |
CA1011506A (en) | Softener-detergent composition | |
AU466337B2 (en) | Vaginal-anal applicator | |
AU472176B2 (en) | Composition | |
AU473444B2 (en) | Therapeutic agents | |
CA1008770A (en) | Therapeutic composition containing 1-(2-hydroxy-2-indanyl)-propylamine | |
CA1005770A (en) | Protease-containg composition | |
CA979730A (en) | Shortening composition | |
AU471785B2 (en) | Therapeutic compositions | |
AU470572B2 (en) | New deodorant-antiperspirant compounds | |
CA977787A (en) | Barres asymetriques | |
AU473116B2 (en) | New proline compounds | |
CA990880A (en) | Tar-urethane composition | |
AU5931473A (en) | Applicator for weedicides | |
CA905413A (en) | 1-(substituted-3-pyrrolidinyl)-3-arylsulfonylureas | |
CA904866A (en) | 1-(omega-substituted-alkyl)-2-methylbenzimidazoles | |
CA907519A (en) | Therapeutic compositions | |
CA897064A (en) | Therapeutic compositions | |
CA911333A (en) | Therapeutic compositions | |
AU478302B2 (en) | Therapeutic compounds | |
CA889817A (en) | Anesthetic composition | |
CA898644A (en) | Medical applicator | |
AU469232B2 (en) | Composition | |
CA983399A (en) | Dental-prophylaxis composition | |
AU469580B2 (en) | Dental-prophylaxis composition |